Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Product name:
SODIUM IODIDE (131I) SOLUTION
DIN:
02439905
Product Monograph/Veterinary Labelling:
Date:
2015-03-24
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
11215 Ch De La Cote-De-Liesse
Dorval
Quebec
Canada
H9P 1B1
Class:
Radiopharmaceutical
Dosage form(s):
Solution
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Schedule C
American Hospital Formulary Service (AHFS): See footnote 3
78:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V10XA01 SODIUM IODIDE 131 I
Active ingredient group (AIG) number:See footnote5
0152597001
| Active ingredient(s) | Strength |
|---|---|
| SODIUM IODIDE 131 I | 37 GBQ / ML |